Overview

Pioglitazone Therapy for Chronic Granulomatous Disease

Status:
Terminated
Trial end date:
2019-10-20
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this proposed research is to investigate the efficacy and safety of the therapy with pioglitazone for chronic granulomatous disease (CGD) patients severe infection.
Phase:
Phase 1/Phase 2
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Children's Hospital of Fudan University
Treatments:
Pioglitazone
Criteria
Inclusion Criteria:

1. Ageļ¼š1 months to 18 years

2. Chronic Granulomatous Disease

3. with severe infections

Exclusion Criteria:

1. > 18 years of age

2. infections are treatable by conventional therapy (antibiotics, antimycotics,
allogeneic granulocytes)